113 related articles for article (PubMed ID: 11983201)
1. Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia.
Salazar A; Mañá J; Pintó X; Argimón JM; Hurtado I; Pujol R
Clin Chim Acta; 2002 Jun; 320(1-2):59-64. PubMed ID: 11983201
[TBL] [Abstract][Full Text] [Related]
2. Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis.
Salazar A; Maña J; Fiol C; Hurtado I; Argimon JM; Pujol R; Pinto X
Atherosclerosis; 2000 Oct; 152(2):497-502. PubMed ID: 10998479
[TBL] [Abstract][Full Text] [Related]
3. Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis.
Salazar A; Maña J; Pinto X; Argimon JM; Castiñeiras MJ; Fiol C; Pujol R
Atherosclerosis; 1998 Jan; 136(1):133-7. PubMed ID: 9580477
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol is reduced in patients with sarcoidosis.
Kindman LA; Gilbert HS; Almenoff JS; Ginsberg H; Fagerstrom R; Teirstein AS
Am J Med; 1989 Apr; 86(4):376-8. PubMed ID: 2929624
[TBL] [Abstract][Full Text] [Related]
5. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
7. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids.
Ettinger WH; Goldberg AP; Applebaum-Bowden D; Hazzard WR
Am J Med; 1987 Sep; 83(3):503-8. PubMed ID: 3661587
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
9. Distribution of low-density lipoprotein and high-density lipoprotein subclasses in patients with sarcoidosis.
Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Spasic S; Videnovic-Ivanov J; Ivanisevic J; Vucinic-Mihailovic V; Gojkovic T
Arch Pathol Lab Med; 2013 Dec; 137(12):1780-7. PubMed ID: 24283859
[TBL] [Abstract][Full Text] [Related]
10. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
[TBL] [Abstract][Full Text] [Related]
11. Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus.
Ettinger WH; Hazzard WR
J Clin Endocrinol Metab; 1988 Sep; 67(3):425-8. PubMed ID: 3410932
[TBL] [Abstract][Full Text] [Related]
12. The influence of prednisone on serum angiotensin-converting enzyme activity in patients with and without sarcoidosis.
Rømer FK; Jacobsen F
Scand J Clin Lab Invest; 1982 Jun; 42(4):377-82. PubMed ID: 6291134
[TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men.
Taskinen MR; Kuusi T; Yki-Järvinen H; Nikkilä EA
J Clin Endocrinol Metab; 1988 Aug; 67(2):291-9. PubMed ID: 3134387
[TBL] [Abstract][Full Text] [Related]
15. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM
Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363
[TBL] [Abstract][Full Text] [Related]
16. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
Filippatos TD; Derdemezis CS; Voulgari PV; Tsimihodimos V; Elisaf MS; Tselepis AD; Drosos AA
Scand J Rheumatol; 2013; 42(3):169-75. PubMed ID: 23311768
[TBL] [Abstract][Full Text] [Related]
17. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with deflazacort in chronic sarcoidosis.
Rizzato G; Fraioli P; Montemurro L
Chest; 1991 Feb; 99(2):301-9. PubMed ID: 1846572
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis.
Lawrence EC; Teague RB; Gottlieb MS; Jhingran SG; Lieberman J
Am J Med; 1983 May; 74(5):747-56. PubMed ID: 6301276
[TBL] [Abstract][Full Text] [Related]
20. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
